TACRUS- tacrolimus ointment 
Pella Pharmaceuticals Co. Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Tacrus

Composition

Tacrus 0.1%
Each1 g contains: Tacrolimus 1 mg.
Excipients: Soft Paraffin, Mineral Oil, Propylene Carbonate, Hard Paraffin and White Beeswax

Indications

The active substance of Tacrus ®, tacrolimus monohydrate, is an immune-modulating agent.
Tacrus ® 0.03% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids and in children (2 years of age and older) who failed to respond adequately to conventional therapies such as topical corticosteroids. Tacrus ® 0.1 % ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.
Once moderate to severe atopic dermatitis is cleared or almost cleared after up to 6 weeks treatment of a flare, and if you are experiencing frequent flares (i.e. 4 oc more per year), it may be possible to prevent flares coming back or prolong the time you are free from flares by using Tacrus ® 0.1% ointment twice weekly.
In atopic dermatitis, an over-reaction of the skin's immune system causes skin inflammation (itchiness, redness, dryness).
Tacrus ® alters the abnormal immune response and relieves the skin inflammation and the itch.

Contraindications

If you are allergic (hypersensitive) to tacrolimus or any of other ingredients of Tacrus or to macrolide anttbiotics (e.g. azithromycin, clarithromycin, erythromycin).

Precautions while taking Tacrus ®

Tell your doctor if you:

Lactation

Don't use Tacrus ® if you are breast-feeding.
Ask your doctor or pharmacist before taking any medicine.

Pregnancy

Don't use Tacrus ® if you are pregnant.
Ask your doctor or pharmcist before taking any medicine.

Drug Interactions

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
You may use moisturizing creams and lotions during treatment with Tacrus® but these products should not be used within two hours of applying Tacrus ®.
The use of Tacrus ® at the same time as other preparations to be used on the skin or while taking oral corticosteroids (e.g. cortisone) or medicines which affect the immune system has not been studied.
Using Tacrus ® with food and drink
While using Tacrus ®, drinking alcohol may cause the skin or face to become flushed or red and feel hot.

Dosage and Administration

Always use Tacrus ® exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

Children (2 years of age and older):
Apply Tacrolimus 0.03% ointment twice a day for up to three weeks, once in the morning and once in the evening. Afterwards the ointment should be used once a day on each affected region of the skin until the eczema has gone away.


Adults (16 years of agc and older):
Two strengths of Tacrolimus (0.03% and 0.1% ointment) are available for adults patients (16 years of age and older). Your doctor will decide which strength is best for you.
Usually, treatment is started with Tacrus ® 0.1% ointment twice a day, once in the morning and once in the evening, until the eczema has cleared. Depending on the response of your eczema your doctor will decide if the frequency of application can be reduced or the lower strength, Tacrolimus 0.03% ointment, can be used.
Treat each affected region of your skin until the eczema has gone away. Improvement is usually seen within one week. If you do not see any improvement after two weeks, see your doctor about other possible treatments. You may be told by your doctor to use Tacrus ® 0.1% ointment twice weekly once your atopic dermatitis has cleared or almost cleared (Tacrolimus 0.03% for children and Tacrs ® 0.1% for adults). Tacrus ® 0.1% ointment should be applied once a day twice weekly (e.g. Monday and Thursday) to areas of your body commonly affected by atopic dermatitis. There should be 2-3 days without Tacrus ® treatment between applications.

If symptoms reappear you should use Tacrus ® twice daily as outlined above and arrange to see your doctor to review your treatment.

Possible Side Effects

Like all medicines, Tacrus ® can cause side effects, although not everybody gets them.

Very common (probably affecting more than 1 in 10): burning sensation and itching; these symptoms are usually mild to moderate and generally go away within one week of using Tacrus ®.

Following twice-weekly treatment application site infections have been reported in children and adults, impetigo, a superficial bacterial skin infection that usually produces blisters or sores on the skin,has been reported in children. Rosaceae (facial redness), Rosaceae- like dermatitis and oedema at the application site has been reported during post marketing experience.


Since commercial availability a very small number of people who have used Tacrolimus ointment have had malignancies (for example, skin and lymphoma). However a link to Tacrolimus ointment has not been confirmed or refuted on the available evidence so far.
If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist.

Overdosage

If you accidentaly swallow some ointment
If you accidentally swallow the ointment, consult your doctor or pharmacist as soon as possible. Do not try to induce Vomiting.
If you forget to use Tacrus ®

If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before. If you have any further questions on the use of this product, ask your doctor or pharmacist.

How supplied

10 g packs.

30 g packs.

Storage

Do not store above 25 °C.
Keep out of the reach and sight of children.
Do not use Tacrus ® after the expiry date which is stated on the tube and carton after Exp. The expiry date refers to the last day of that month.

THIS IS A MEDICAMENT

Secondary Package 10 g

Secondary Package

Secondary Package 30 g

Secondary Package

Primary Package 30 g

Primary Package

Primary Package 10 g

Primary Package

TACRUS 
tacrolimus ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:82160-124
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J) TACROLIMUS ANHYDROUS30 mg  in 30 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:82160-124-011 in 1 CARTON12/11/2014
130 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:82160-124-021 in 1 CARTON12/11/2014
210 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/11/2014
Labeler - Pella Pharmaceuticals Co. Ltd (562370925)

Revised: 12/2023
Document Id: 0d6bf85c-3bbc-4b8d-e063-6294a90a728e
Set id: d0815b7a-46e5-0605-e053-2a95a90a78a8
Version: 127
Effective Time: 20231226
 
Pella Pharmaceuticals Co. Ltd